Optibrium Launches PyMOL Plugin for QuanSA to Streamline 3D Ligand-Based Binding Affinity Predictions

Optibrium launches a new PyMOL plugin for QuanSA, providing chemists with a visual GUI for accurate, low-cost ligand-based binding affinity predictions.

By: AXL Media

Published: Mar 25, 2026, 5:51 AM EDT

Source: Information for this report was sourced from Optibrium Ltd.

Democratizing High-Fidelity Molecular Modeling

The transition of sophisticated computational tools from command-line environments to intuitive graphical interfaces represents a significant shift in drug discovery accessibility. Optibrium’s introduction of the QuanSA plugin for PyMOL aims to bridge the gap between expert computational researchers and the broader chemistry community. By providing a visual layer to its Quantitative Surface-Field Analysis method, the company is enabling medicinal chemists to directly interact with complex 3D models, reducing the technical barriers typically associated with high-accuracy affinity predictions during the lead optimization phase.

Predictive Accuracy Without Protein Structural Data

A distinguishing feature of the QuanSA method is its ability to deliver binding affinity predictions that rival leading simulation-based techniques, such as free energy perturbation, without requiring a solved protein structure. This ligand-based approach utilizes a physically-motivated machine learning framework to model the factors governing molecular recognition. Because it does not rely on static protein templates, the tool can be deployed much earlier in the drug discovery lifecycle, making it applicable to a wider array of biological targets where structural data might be incomplete or entirely unavailable.

Visualizing Steric and Chemical Affinity Drivers

The new PyMOL interface provides researchers with a clear visual output that identifies the specific interactions driving a molecule's potency. For instance, the software can differentiate between structurally similar compounds by highlighting subtle steric contributions or hydrogen bonding patterns that result in vastly different affinity levels. These visualizations, often represented as colored cones or highlighted surface patches, allow teams to see not just how strongly a molecule binds, but the specific geometric reasons why, facilitating more informed decisions during the design of potent pre-clinical candidates.